ciclopirox has been researched along with Candida Infection in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Flucytosine (5FC) has shown synergistic effect with AmB for treatment of some fungal infections, such as cryptococcosis, but again, its price is a limitation for its use in many regions." | 3.96 | Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and ( Agreda-Mellon, D; de Oliveira, HC; García-Cambero, JP; Lucio, J; Mendes-Giannini, MJS; Rossi, SA; Zaragoza, O, 2020) |
| "Ciclopirox also displays mild anti-inflammatory effects in biochemical and pharmacological models; effects also shown in small clinical studies." | 2.46 | Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. ( Mailland, F; Monti, D; Subissi, A; Togni, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, SA | 1 |
| de Oliveira, HC | 1 |
| Agreda-Mellon, D | 1 |
| Lucio, J | 1 |
| Mendes-Giannini, MJS | 1 |
| García-Cambero, JP | 1 |
| Zaragoza, O | 1 |
| Meykadeh, N | 1 |
| Waltermann, K | 1 |
| Schaller, M | 2 |
| Marsch, WC | 1 |
| Fischer, M | 1 |
| Subissi, A | 1 |
| Monti, D | 1 |
| Togni, G | 1 |
| Mailland, F | 1 |
| Sardana, K | 1 |
| Garg, VK | 1 |
| Manchanda, V | 1 |
| Rajpal, M | 1 |
| Figueiredo, VT | 1 |
| de Assis Santos, D | 1 |
| Resende, MA | 1 |
| Hamdan, JS | 1 |
| Czaika, V | 1 |
| Tietz, HJ | 1 |
| Schmalreck, A | 1 |
| Sterry, W | 1 |
| Schultze, W | 1 |
| Niewerth, M | 1 |
| Korting, HC | 1 |
| Hube, B | 1 |
| Baran, R | 1 |
| Nencioni, T | 1 |
| Pamparana, F | 1 |
| Jacobellis, M | 1 |
| Griffith, ML | 1 |
| Flowers, FP | 1 |
| Araujo, OE | 1 |
1 review available for ciclopirox and Candida Infection
| Article | Year |
|---|---|
Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Ciclopirox; | 2010 |
1 trial available for ciclopirox and Candida Infection
| Article | Year |
|---|---|
[Mycotic vulvovaginitis and topical cyclopiroxolamine].
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis; Ciclopirox; Clinical Trials as | 1988 |
8 other studies available for ciclopirox and Candida Infection
| Article | Year |
|---|---|
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Topics: Amphotericin B; Animals; Antifungal Agents; Auranofin; Candida albicans; Candidiasis; Cell Line; Cic | 2020 |
Bullous ulcerating tinea.
Topics: Adolescent; Antifungal Agents; Blister; Candidiasis; Ciclopirox; Female; Humans; Itraconazole; Pyrid | 2009 |
Congenital candidal onychomycoses: effective cure with ciclopirox olamine 8% nail lacquer.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Hand Dermatoses; Humans; Infant | 2006 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; I | 2007 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Flucon | 2000 |
[Mode of action of ciclopiroxolamine on Candida albicans].
Topics: Candida albicans; Candidiasis; Ciclopirox; Humans; Microbial Sensitivity Tests; Pyridones | 2002 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; H | 1992 |
Superficial mycoses. Therapeutic agents and clinical applications.
Topics: Antifungal Agents; Candidiasis; Ciclopirox; Griseofulvin; Humans; Imidazoles; Phenyl Ethers; Pyridon | 1986 |